| View |
|
DRP-9415-03
|
Iohexol
|
Prohexon 350
|
755 mg/mL (eq. to 350 mg/mL Iodine)
|
Solution for Injection
|
Prescription Drug (Rx)
|
Type I clear glass molded glass vial stoppered with 31 mm grey chlorobutyl RTU rubber stopper, 32 mm grey bromobutyl RTU rubber stopper and sealed with 33 mm purple aluminum flip off seal x 50 mL / (Box of 1's)
|
X-ray Contrast media, Iodinated (Watersoluble, Nephrotropic, Low Osmolar)
|
Jodas Expoim Pvt. Ltd.
|
India
|
|
Bliss Pharma Distribution and Consultancy Corp.
|
Kinmed Healthcare Trading Corp
|
CLIDP Conversion
|
28 March 2024
|
23 December 2025
|
| View |
|
DRP-9415-04
|
Iohexol
|
Hexolin 350
|
755 mg/mL (eq. to 350 mg/mL Iodine)
|
Solution for Injection (Intravascular/Intraarticular/Oral or Rectal Administration/Oral in Conjunction with Intravenous Administration/Body Cavity)
|
Prescription Drug (Rx)
|
Type I clear molded glass vial stoppered with 31 mm grey chlorobutyl RTU rubber stopper, 32 mm grey bromobutyl RTU rubber stopper and sealed with 33 mm purple aluminium flip off seal x 50 mL / (Box of 1's)
|
X-ray Contrast Media, Iodinated (Watersoluble, Neprotropic, Low Osmolar)
|
Jodas Expoim Pvt. Ltd
|
India
|
|
Bliss Pharma Distribution and Consultancy Corp.
|
Amediqo Phils., Inc
|
CLIDP Conversion
|
28 April 2024
|
23 December 2025
|
| View |
|
DRP-9416
|
Iohexol
|
Jodascan
|
647 mg/ mL (eq. to 300 mg/ mL Iodine)
|
Solution for Injection (Intrathecal/Intravascular/Intraarticular/Oral or Rectal Administration/Oral in Conjunction with
Intravenous Administration/Body Cavity)
|
Prescription Drug (RX)
|
Type 1 clear molded glass vial stoppered with 31mm grey chlorobutyl RTU rubber stopper, 32mm grey chlorobutyl RTU rubber stopper and sealed with 33mm purple aluminum flip off seal x 50mL
|
X-ray Contrast Media, Iodinated (Watersoluble, Nephrotropic, Low osmolar)
|
JODAS EXPOIM PVT. LTD.
|
India
|
|
Bliss Pharma Distribution and Consultancy Corp.
|
Bliss Pharma Distribution and Consultancy Corp.
|
Initial
|
23 December 2020
|
23 December 2025
|
| View |
|
DRP-9416-01
|
Iohexol
|
Hexolfree 300
|
647 mg/mL (eq. to 300 mg/mL Iodine)
|
Solution for Injection (Intrathecal/Intravascular/Intraarticular/Oral or Rectal Administration/Oral in Conjunction with Intravenous Administration/Body Cavity)
|
Prescription Drug (Rx)
|
Type I clear molded glass vial stoppered with 31 mm grey chlorobutyl RTU rubber stopper, 32 mm grey bromobutyl RTU rubber stopper and sealed with 33 mm purple aluminum flip-off seal x 50 mL (Box of 1's)
|
-
|
Jodas Expoim Pvt. Ltd.
|
India
|
N/A
|
Bliss Pharma Distribution and Consultancy Corp
|
Afree Pharmaceutical Distribution Corp
|
CLIDP Conversion
|
13 December 2022
|
23 December 2025
|
| View |
|
DRP-9416-02
|
Iohexol
|
Kinhexol
|
647 mg/ mL (eq. to 300 mg/ mL Iodine)
|
Solution for Injection (Intrathecal/ Intravascular/ Intraarticular/ Oral or Rectal Administration/ Oral in Conjunction with Intravenous Administration/ Body Cavity)
|
Prescription Drug (Rx)
|
Type I clear molded glass vial stoppered with 31 mm grey chlorobutyl RTU rubber stopper, 32 mm grey bromobutyl RTU rubber stopper and sealed with 33 mm purple aluminum flip off seal x 50 mL (Box of 1's)
|
X-Ray Contrast Media, Iodinated (Watersoluble, Nephrotropic, Low osmolar)
|
Jodas Expoim Pvt. Ltd
|
India
|
N/A
|
Bliss Pharma Distribution and Consultancy Corp
|
Kinmed Healthcare Trading Corp.
|
CLIDP Conversion
|
31 January 2024
|
23 December 2025
|
| View |
|
DRP-9416-03
|
Iohexol
|
Hextar
|
647 mg/mL (eq. to 300mg/mL Iodine)
|
Solution for Injection
|
Prescription Drug (Rx)
|
Type I clear molded glass vial stoppered with 31 mm grey chlorobutyl RTU rubber stopper, 32 mm grey bromobutyl RTU rubber stopper and sealed with 33 mm purple aluminum flip-off seal x 50 mL / (Box of 1's)
|
X-Ray Contrast Media, Iodinated (Water soluble, Nephrotropic, Low Osmolar)
|
Jodas Expoim Pvt. Ltd.
|
India
|
|
Bliss Pharma Distribution and Consultancy Corp. /
Pharmastar Int'l Trading Corp.
|
|
CLIDP Conversion
|
26 February 2024
|
23 December 2025
|
| View |
|
DRP-9416-04
|
Iohexol
|
Prohexon 300
|
647 mg/mL (eq. to 300 mg/mL Iodine)
|
Solution for Injection (Intrathecal/Intravascular/Intraarticular/Oral or Rectal Administration/Oral in conjunction with Intraveous Administration/Body cavity)
|
Prescription Drug (Rx)
|
Type I clear molded glass vial stoppered with 31 mm grey chlorobutyl RTU rubber stopper, 32 mm grey bromobutyl RTU rubber stopper and sealed with 33 mm purple aluminum flip off seal x 50 mL / (Box of 1's)
|
X-ray Contrast Media, Iodinated (Watersoluble, Nephrotropic, Low Osmolar)
|
Jodas Expoim Pvt. Ltd.
|
India
|
|
Bliss Pharma Distribution and Consultancy Corp
|
Ellebasy Medicale Group Inc
|
CLIDP Conversion
|
15 April 2024
|
23 December 2025
|
| View |
|
DRP-9416-05
|
Iohexol
|
Hexolin 300
|
647 mg/mL (eq. to 300 mg/mL Iodine)
|
Solution for Injection (Intrathecal/Intravascular/Intraarticular/Oral or Rectal Administration/Oral in Conjunction with Intravenous Administration/Body Cavity)
|
Prescription Drug (Rx)
|
Type I clear molded glass vial stoppered with 31 mm grey chlorobutyl RTU rubber stopper, 32 mm grey bromobutyl RTU rubber stopper and sealed with 33 mm purple aluminium flip off seal x 50 mL / (Box of 1's)
|
X-ray Contrast Media, Iodinated (Watersoluble, Nephrotropic, Low Osmolar)
|
Jodas Expoim Pvt. Ltd
|
India
|
|
Bliss Pharma Distribution and Consultancy Corp
|
Amediqo Phils., Inc
|
CLIDP Conversion
|
28 April 2024
|
23 December 2025
|
| View |
|
DRP-9417
|
Trimetazidine dihydrochloride
|
Trioxo Mr
|
35 mg
|
Modified Release Tablet
|
Prescription Drug (RX)
|
Alu/PVC/PVDC Blister Pack x 10's (Box of 30's and 100's)
|
-
|
Globela Pharma Pvt. Ltd.
|
India
|
|
AMB HK Enterprises Inc.
|
AMB HK Enterprises Inc.
|
-
|
23 December 2020
|
23 December 2025
|
| View |
|
DRP-9417-01
|
Trimetazidine Dihydrochloride
|
Triophil
|
35 mg
|
Modified Release Tablet
|
Prescription Drug (RX)
|
Alu/PVC-PVDC Blister Pack x 10's (Box of 30's and 100's)
|
-
|
Globela Pharma Private Limited
|
India
|
|
AMB HK Enterprises Inc.
|
PhilRx Pharma Inc.
|
-
|
24 August 2021
|
23 December 2025
|
| View |
|
DRP-9417-02
|
Trimetazidine dihydrochloride
|
Metalife
|
35 mg
|
Modified Release Tablet
|
Prescription Drug (Rx)
|
Alu/PVC/PVDC Blister Pack x 10's / (Box of 30's and 100's)
|
Antianginal Agent (Fatty Acid Oxidation (pFOX) Inhibitor)
|
Globela Pharma Private Limited
|
India
|
|
AMB HK Enterprises Inc.
|
Life and Health Source Pharmaceutical Distribution Co.
|
CLIDP Conversion
|
18 June 2024
|
23 December 2025
|
| View |
|
DRP-9418
|
Mefenamic Acid
|
Mecid
|
500 mg
|
Capsule
|
Prescription Drug (RX)
|
Alu/PVC Blister Pack x 10's (Box of 100's)
|
Non-Steroidal Anti-Inflammatory Drug/NSAID (Fenamate)
|
Jiangxi Xi'erkangtai Pharmaceutical Co., Ltd.
|
China
|
|
PhilRx Pharma Inc.
|
PhilRx Pharma Inc.
|
Renewal
|
23 December 2020
|
10 October 2028
|
| View |
|
DRP-9418-01
|
Mefenamic Acid
|
None
|
500 mg
|
Capsule
|
Prescription Drug (Rx)
|
Alu/PVC Blister Pack x 10's (Box of 100's)
|
Non-Steroidal Anti-Inflammatory Drug/NSAID (Fenamate)
|
Jiangxi Xierkangtai Pharmaceutical Co., Ltd.
|
China
|
N/A
|
PhilRx Pharma Inc
|
Cyden Medicale Trading Inc.
|
CLIDP Conversion
|
04 January 2024
|
10 October 2028
|
| View |
|
DRP-942
|
Co-Amoxiclav
|
Comox
|
50 mg/62.5 mg per 5 mL
|
Powder For Suspension
|
Prescription Drug (Rx)
|
Plastic Bottle x 60 mL (Box of 1's)
|
Antibacterial (Penicillin + Beta-Lactamse Inhibitor combination)
|
Lloyd Laboratories, Inc
|
Philippines
|
Aldril Pharmaceuticals, Inc.
|
|
N/A
|
Automatic Renewal
|
28 November 2022
|
18 December 2027
|
| View |
DRP-942-01_PI_01.pdf
|
DRP-942-01
|
Co-Amoxiclav
|
Solvamox
|
250 mg/ 62.5 mg per 5 mL
|
Powder For Suspension
|
Prescription Drug (Rx)
|
Plastic Bottle x 60 mL (Box of 1's)
|
Antibacterial (Penicillin/Beta-Lactamse Inhibitor Combination)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Aldril Pharmaceuticals, Inc.
|
|
Solvang Pharmaceuticals, Inc.
|
Automatic Renewal
|
11 February 2023
|
18 December 2027
|
| View |
|
DRP-942-02
|
Co-Amoxiclav
|
Clavic
|
250 mg/62.5 mg per 5 mL
|
Powder For Suspension
|
Prescription Drug (RX)
|
Plastic Bottle x 60 mL (Box of 1's)
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor Combinaton)
|
Lloyd Laboratories, Inc.
|
Philippines
|
|
|
Vitalink Health Products, Inc.
|
Automatic Renewal
|
25 January 2023
|
18 December 2027
|
| View |
|
DRP-942-03
|
Co-Amoxiclav
|
Lactamox
|
250 mg/62.5 mg per 5 mL
|
Powder For Suspension
|
Prescription Drug (Rx)
|
Plastic Bottle x 60 mL (Box of 1's)
|
Antibacterial (Penicillin/Beta-Lactamse Inhibitor Combination)
|
Lloyd Laboratores, Inc.
|
Philippines
|
Aldril Pharmaceuticals, Inc.
|
|
Totalcare Pharma Inc.
|
Automatic Renewal
|
15 December 2022
|
18 December 2027
|
| View |
|
DRP-942-04
|
Co-Amoxiclav
|
Claxic
|
250 mg/62.5 mg per 5 mL
|
Powder For Suspension
|
Prescription Drug (RX)
|
Plastic Bottle x. 60 mL (Box of 1's)
|
Antibacterial (Penicillin/Beta-Lactamase combination)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Aldril Pharmaceuticals, Inc.
|
|
Metz Pharmaceuticals, Inc.
|
Automatic Renewal
|
27 December 2022
|
18 December 2027
|
| View |
|
DRP-9420
|
Omeprazole
|
Ranzole
|
40 mg
|
Delayed Release Tablet
|
Prescription Drug (RX)
|
.Alu/Alu Blister Pack x 10's (Box of 100's)
|
Proton Pump Inhibitor
|
Jiangxi Xierkangtai Pharmaceutical Co., Ltd.
|
China
|
|
PhilRx Pharma Inc.
|
PhilRx Pharma Inc.
|
Renewal
|
02 August 2023
|
05 December 2028
|
| View |
|
DRP-9420-01
|
Omeprazole
|
Qmeprazole
|
40 mg
|
Delayed-Release Capsule
|
Prescription Drug (Rx)
|
Alu/Alu Blister Pack x 10's / (Box of 100's)
|
Proton Pump Inhibitor
|
Jiangxi Xierkangtai Pharmaceutical Co., Ltd
|
China
|
|
PHILRX PHARMA INC
|
QUAD-GEN PHARMACEUTICALS
|
CLIDP Conversion
|
26 March 2024
|
05 December 2028
|